International Cannabis Weekly: 359

CBD CONSORTIUM APPLICATION CLEARS FIRST HURDLE WITH FSA APPROVAL 

The UK’s Food Standards Agency (FSA) has issued its first positive safety assessment for a consortium application in its CBD Novel Foods approval process.

READ MORE  »

COMMERCIAL CANNABIS MARKET STILL A GOAL FOR CZECH REPUBLIC

READ MORE »

CBD BRAND, VOYAGER LIFE, SEEKS OUT FROM CANNABIS MARKET

READ MORE »

• The Italian region of Puglia gets ball rolling for hemp production project worth €250,000 worth of funding.
• UK CBD maker, B3 Labs, closes amid 500+ products awaiting safety approval from the FSA.
• Tilray receives first new cannabis cultivation license for Aphria RXin Germany facility under new regulations.
• One of Germany’s leading cannabis companies, Sanity Group, secures additional growth capital worth €17m.
• Germany has adopted new guidelines that will allow medical cannabis to be prescribed by specialists.
• Tilray Medical gets the go-ahead to introduce third medical cannabis product in Portugal, with their oral solution.

• Feds to look at 40,000+ cannabis rescheduling comments from Governors, Lawmakers, Health Experts & Advocates.
• How has Kamala Harris’ position on cannabis has evolved over the years to become more progressive?
• Nurses in the U.S. throw support behind rescheduling of cannabis from Schedule I to III, with upcoming review.
• Althea Group expands into booming U.S. cannabis drink market, launching 6 THC-infused beverages from Canada.
• 27% of US cannabis operators are profitable, according to economist at Benzinga Cannabis Capital Conference.
• Local Texas officials certify signatures to put cannabis decriminalization on Dallas’s November ballot paper.

• Canadian cannabis sales growth has slowed down, in figures up to the month of May.
• Organigram to bolster auto-flower & rare cannabinoid portfolio with partial Third Tranche investment into Phylos.
• THC levels wrong on 40% of oils sold by Ontario Cannabis Store, lab testing shows, as per McMaster University.
• Cannabis Q2 earnings season approaches, following mid-May’s “unexciting” Q1 reports.
• New federal cannabis licences continue to slow down, with micros claiming top spot as of March 2024.
• Federal government reviews recommendations, provides response to petition to increase THC limit for edibles.

• Bahamas Attorney General highlights entrepreneurial opportunities cannabis bills will facilitate, in Senate speech.
• In Argentina, MisioPharma will open a medical cannabis clinic in the Posadas Health Park ahead of other provinces.
• Puerto Rican reggae band Cultura Profética launch their own cannabis strain, called “Mota”.
• Uruguay ventures into nuclear technology for the development of food & cannabis, with feasibility study to go ahead.

• Thailand will not re-criminalize cannabis, deputy PM says – in U-turn that opens door towards medical use in the country.
• Cann Group confirms Jenni Pilcher as chief executive and managing director after almost four months in interim role.
• Cann Group outlines growth and market plans, with upcoming webinar planned to unveil Q4 plans to investors.
• “Everyone should have the right to grow their own cannabis if they wish”, tells cannabis advocate to jury in NZ case.

• Promising results in medical cannabis: CannaMore’s successful phase 2a trial for Colitis treatment in study.
• In South Africa, hear about 23 enterprises to develop & market high-quality cannabis for local and international markets.